Dr Agarwal's Eye Hospital Ltd
BSE:526783
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 622.95
5 535.7002
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Dr Agarwal's Eye Hospital Ltd
Dr Agarwal's Eye Hospital Ltd
PP&E Net
Dr Agarwal's Eye Hospital Ltd
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Dr Agarwal's Eye Hospital Ltd
BSE:526783
|
PP&E Net
₹4.1B
|
CAGR 3-Years
63%
|
CAGR 5-Years
51%
|
CAGR 10-Years
33%
|
|
|
Thyrocare Technologies Ltd
NSE:THYROCARE
|
PP&E Net
₹2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
PP&E Net
₹3.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Vijaya Diagnostic Centre Ltd
NSE:VIJAYA
|
PP&E Net
₹5.4B
|
CAGR 3-Years
26%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Krsnaa Diagnostics Ltd
NSE:KRSNAA
|
PP&E Net
₹6.5B
|
CAGR 3-Years
28%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Metropolis Healthcare Ltd
NSE:METROPOLIS
|
PP&E Net
₹3.4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Dr Agarwal's Eye Hospital Ltd
Glance View
Dr. Agarwal's Eye Hospital Ltd. operates as an eye hospital, which engages in the provision of eye care solutions. The company is headquartered in Chennai, Tamil Nadu. The firm provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti vegf, dry eyes, scleral buckle, pre descemets endothelial keratoplasty (PDEK), refractive surgery and paediatric ophthalmology. The company also provides treatment for cataract, glaucoma, squint, diabetic retinopathy, retinal detachment, retinopathy prematurity, macular edema, traumatic cataract, macular hole, posterior subcapsular cataract, rosette cataract and congenital glaucoma. The firm provides its services in various locations in India, including Tamil Nadu, Karnataka, Maharashtra, Kerala, West Bengal, Odisha, Andhra Pradesh, Puducherry, Gujarat, Rajasthan, Madhya Pradesh and Andaman.
See Also
What is Dr Agarwal's Eye Hospital Ltd's PP&E Net?
PP&E Net
4.1B
INR
Based on the financial report for Jun 30, 2024, Dr Agarwal's Eye Hospital Ltd's PP&E Net amounts to 4.1B INR.
What is Dr Agarwal's Eye Hospital Ltd's PP&E Net growth rate?
PP&E Net CAGR 10Y
33%
Over the last year, the PP&E Net growth was 28%. The average annual PP&E Net growth rates for Dr Agarwal's Eye Hospital Ltd have been 63% over the past three years , 51% over the past five years , and 33% over the past ten years .
You don't have any saved screeners yet
